BAP1 and nonpapillary renal cell carcinoma: The same group (Kocak et al., 2020) then developed an RF-based radiogenomic model for the prediction of BAP1 mutation status, which carries poor prognostic implications in ccRCC [20,21,25], in a subset of 65 patients from TCGA-KIRC (13 with and 52 without BAP1 mutation).